Procalcitonin for Diagnosing Infections and Guiding Antibiotic Use
Author Information
Author(s): Philipp Schuetz, Wernher Albrich, Beat Mueller
Primary Institution: Harvard School of Public Health
Hypothesis
Can procalcitonin (PCT) improve the diagnosis of bacterial infections and guide antibiotic therapy?
Conclusion
Procalcitonin can effectively guide antibiotic decisions in certain infections, reducing unnecessary antibiotic use.
Supporting Evidence
- Procalcitonin levels correlate with the severity of bacterial infections.
- Randomized-controlled trials show that PCT can reduce antibiotic exposure without adverse outcomes.
- Observational studies suggest PCT may help in diagnosing various types of infections.
Takeaway
Procalcitonin is a special marker that helps doctors know if a patient has a bacterial infection and if they really need antibiotics.
Methodology
This review summarizes evidence from randomized-controlled trials and observational studies regarding the use of procalcitonin in diagnosing infections and guiding antibiotic therapy.
Potential Biases
Potential biases include observer bias and selection bias in the studies reviewed.
Limitations
The review highlights that many studies have limitations such as differences in patient populations and the lack of a true gold standard for diagnosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website